PUBLISHER: 360iResearch | PRODUCT CODE: 1615474
PUBLISHER: 360iResearch | PRODUCT CODE: 1615474
Gut Health Nutraceuticals Market by Product (Enzymes, Fulvic Acid, Prebiotics), Form (Capsules, Liquids, Powders), Distribution Chanel - Global Forecast 2025-2030
The Gut Health Nutraceuticals Market was valued at USD 11.29 billion in 2023, expected to reach USD 12.07 billion in 2024, and is projected to grow at a CAGR of 7.43%, to USD 18.65 billion by 2030.
The Gut Health Nutraceuticals market encompasses dietary supplements and functional foods designed to support digestive health, leveraging ingredients like probiotics, prebiotics, fibers, and plant extracts. These products are essential as they cater to a growing consumer awareness about the crucial role of gut health in overall well-being, immunity, and mental health. Applications extend across various age groups, with end-use spanning households, healthcare facilities, and health-conscious individuals. Market growth is propelled by increasing consumer inclination towards preventive healthcare, and innovative product formulations, coupled with scientific validation of gut-brain axis significance, foster growth. The rising incidence of digestive disorders fuels demand, as does the trend of personalized nutrition. Key opportunities lie in expanding distribution channels, including e-commerce platforms, and developing region-specific products addressing local dietary habits. Companies can capitalize on these opportunities by investing in R&D to discover novel ingredients and delivery technologies, targeting niches such as vegan or allergen-free formulations. Collaborations with healthcare providers for consumer education can further enhance market penetration.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 11.29 billion |
| Estimated Year [2024] | USD 12.07 billion |
| Forecast Year [2030] | USD 18.65 billion |
| CAGR (%) | 7.43% |
Despite optimism, the market faces challenges, such as regulatory scrutiny concerning claims around efficacy and safety, necessitating rigorous clinical evidence for product approval. The high cost of quality raw materials and production processes can impede market growth. Additionally, varying regional regulations and consumer skepticism due to misinformation can limit potential. Innovation and research opportunities are abundant in streamlining supply chains, enhancing bioavailability of ingredients, and developing synbiotics - a combination of pro- and prebiotics. Integrating big data and artificial intelligence to analyze consumer behavior and predict trends can provide actionable insights. The market is dynamic, characterized by rapid innovations, yet fragmented, suggesting potential for mergers and acquisitions to consolidate positions. A strategic focus on sustainability, transparency, and regulatory compliance can emerge as differentiators in capturing greater market share.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gut Health Nutraceuticals Market
The Gut Health Nutraceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing consumer knowledge about the benefits of gut health
- Rising prevalence of gastrointestinal disorders worldwide
- Shift towards preventive healthcare and wellness trends
- Market Restraints
- Strict government regulations for approvals of gut health nutraceuticals
- Market Opportunities
- Potential for personalized nutrition for tailored gut health solutions
- Deployment of gut health nutraceuticals on eCommerce platforms
- Market Challenges
- Skepticism about the efficacy of nutraceutical products
Porter's Five Forces: A Strategic Tool for Navigating the Gut Health Nutraceuticals Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gut Health Nutraceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Gut Health Nutraceuticals Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gut Health Nutraceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Gut Health Nutraceuticals Market
A detailed market share analysis in the Gut Health Nutraceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gut Health Nutraceuticals Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gut Health Nutraceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Gut Health Nutraceuticals Market
A strategic analysis of the Gut Health Nutraceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Gut Health Nutraceuticals Market, highlighting leading vendors and their innovative profiles. These include Alimentary Health Limited, Amway Corporation, Archer-Daniels-Midland Company, BASF SE, Bayer AG, FANCL Corporation, Garden of Life, Glanbia Nutritional, GNC Holdings Inc., HealthForce', Herbalife Nutrition Ltd., Himalaya Wellness Company, Koninklijke DSM N.V., Lonza Group Ltd, Nestle Health Science S.A., NOW Health Group, Inc., Nutrica NV by Danone S.A., Olly Nutrition, PanTheryx Inc., Pfizer Inc., Sanofi S.A., The Nature's Bounty Co., and Zenwise, LLC.
Market Segmentation & Coverage
This research report categorizes the Gut Health Nutraceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Enzymes, Fulvic Acid, Prebiotics, and Probiotics.
- Based on Form, market is studied across Capsules, Liquids, Powders, and Tablets.
- Based on Distribution Chanel, market is studied across Offline and Online.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing consumer knowledge about the benefits of gut health
- 5.1.1.2. Rising prevalence of gastrointestinal disorders worldwide
- 5.1.1.3. Shift towards preventive healthcare and wellness trends
- 5.1.2. Restraints
- 5.1.2.1. Strict government regulations for approvals of gut health nutraceuticals
- 5.1.3. Opportunities
- 5.1.3.1. Potential for personalized nutrition for tailored gut health solutions
- 5.1.3.2. Deployment of gut health nutraceuticals on eCommerce platforms
- 5.1.4. Challenges
- 5.1.4.1. Skepticism about the efficacy of nutraceutical products
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing preference for probiotics owing to its contribution in balancing gut microbiota
- 5.2.2. Form: Growing adoption of a tablet form of gut health nutraceuticals due to convenience and durability for storage and transport.
- 5.2.3. Distribution Chanel: Evolving online distribution channels for gut health nutraceuticals
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Gut Health Nutraceuticals Market, by Product
- 6.1. Introduction
- 6.2. Enzymes
- 6.3. Fulvic Acid
- 6.4. Prebiotics
- 6.5. Probiotics
7. Gut Health Nutraceuticals Market, by Form
- 7.1. Introduction
- 7.2. Capsules
- 7.3. Liquids
- 7.4. Powders
- 7.5. Tablets
8. Gut Health Nutraceuticals Market, by Distribution Chanel
- 8.1. Introduction
- 8.2. Offline
- 8.3. Online
9. Americas Gut Health Nutraceuticals Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Gut Health Nutraceuticals Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Gut Health Nutraceuticals Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. Acutia Launches Holistic Dietary Supplement for Digestive Health In Compostable Packaging
- 12.3.2. Nestle Health Science launches 'Resource Fiber Choice' to improve gut health
- 12.3.3. Nutrazee Unveils Probiotic Gummies For Digestive And Immune Health
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Alimentary Health Limited
- 2. Amway Corporation
- 3. Archer-Daniels-Midland Company
- 4. BASF SE
- 5. Bayer AG
- 6. FANCL Corporation
- 7. Garden of Life
- 8. Glanbia Nutritional
- 9. GNC Holdings Inc.
- 10. HealthForce'
- 11. Herbalife Nutrition Ltd.
- 12. Himalaya Wellness Company
- 13. Koninklijke DSM N.V.
- 14. Lonza Group Ltd
- 15. Nestle Health Science S.A.
- 16. NOW Health Group, Inc.
- 17. Nutrica NV by Danone S.A.
- 18. Olly Nutrition
- 19. PanTheryx Inc.
- 20. Pfizer Inc.
- 21. Sanofi S.A.
- 22. The Nature's Bounty Co.
- 23. Zenwise, LLC
LIST OF FIGURES
- FIGURE 1. GUT HEALTH NUTRACEUTICALS MARKET RESEARCH PROCESS
- FIGURE 2. GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. GUT HEALTH NUTRACEUTICALS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. GUT HEALTH NUTRACEUTICALS MARKET DYNAMICS
- TABLE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 24. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 25. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 26. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 27. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 28. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 29. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 30. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 31. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 32. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 33. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 34. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 35. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 37. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 38. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 39. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 41. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 42. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 43. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 44. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 45. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 46. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 47. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 48. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 49. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 50. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 51. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 52. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 53. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 54. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 55. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 56. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 57. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 58. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 59. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 60. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 61. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 62. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 63. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 64. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 65. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 66. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 67. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 68. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 69. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 70. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 71. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 72. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 73. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 74. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 75. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 76. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 77. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 78. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 79. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 81. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 82. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 83. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 84. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 85. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 86. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 87. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 88. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 89. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 90. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 91. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 92. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 93. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 94. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 95. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 96. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 97. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 98. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 99. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 100. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 101. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 102. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 103. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 104. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 105. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 106. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 107. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 108. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 109. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 110. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 111. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 112. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 113. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 114. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 115. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 116. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 117. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 118. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 119. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 120. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 121. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 122. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 123. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 124. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 125. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 126. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 127. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 128. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 129. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 130. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 131. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 132. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 133. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 134. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 135. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 136. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 137. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 138. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 139. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 140. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 141. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 142. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 143. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 144. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 145. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 146. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 147. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 148. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
